Browse by category

The FDA has approved Eli Lilly and Company’s Zepbound (tirzepatide) as the first and only prescription medicine for adults with...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Bariatric surgery performed in patients with obesity and moderate to severe obstructive sleep apnoea is associated with a significantly...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Eli Lilly and Company has announced positive topline results from the SURMOUNT-OSA phase 3 clinical trials that showed tirzepatide...

Hypoglossal nerve stimulation (HGNS) treatment for obstructive sleep apnoea (OSA) drops significantly as a patient's weight rises above a...

The FDA has accepted, and is in the process of reviewing, the ProSomnus’ premarket notification for its ProSomnus EVO precision medical...

The First Line Obstructive Sleep Apnea Treatment study (FLOSAT) clinical trial assessing ProSomnus, a CPAP alternative for the treatment...

Researchers have found that people with have an increased cardiovascular risk due to reduced blood oxygen levels, largely explained by...

Researchers from the UK, Germany, and Australia have shown for the first time that obstructive sleep apnoea (OSA) in middle-aged men can...